New York, September 1 (IANS): The Covid-19 vaccine candidate developed by Oxford University in partnership with the UK-based global biopharmaceutical company AstraZeneca has reached Phase-3 trial in the US.
Wednesday, 5th November, 2025
Support The Morung Express. Your Contributions Matter Click Here
Health
New Delhi, August 31 (IANS): Severe cases of Covid-19 with pre-existing acute cardiovascular underlying condition are at a greater fatality risk. The death rate in such patients is estimated up to 15X higher
New Delhi, August 31 (PTI): The rise in number of COVID-19 cases should not be a cause of concern as long as the number of serious patients and deaths due to the disease remain low, say public health experts in
Mysuru (Karnataka), August 30 (IANS): Clinical trial of the Covishield vaccine, developed by the University of Oxford, began at the JSS Hospital in Mysuru, an official said on Sunday. "The clinical tria
Seoul, August 29 (IANS) Scientists have urged people with atrial fibrillation -- the most common heart rhythm disorder -- to quit smoking if they want to reduce stroke risk. Previous studies have shown that
London, August 28 (IANS): The British government on Friday proposed measures to give emergency approval to a safe and effective Covid-19 vaccine and train a large number of people in administering it in order t
New York, August 28 (IANS): Researchers have revealed that estrogen may lessen the severity of Covid-19 symptoms in women, adding that this may be the reason why men are at a greater risk than women for more se
New York, August 28 (IANS): India is on course to have an "approved" vaccine within the first quarter of calendar year 2021 and Pune based Serum Institute of India (SII), the world's largest vacci
New York, August 28 (IANS): It's widely known fact that Covid-19 can spread rapidly among residents in nursing homes and now, Johns Hopkins study shows people receiving hemodialysis for chronic kidney disea
New Delhi, August 27 (IANS): The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will be beginning the Phase II trial of oxford Covid-19 vaccine candidate -- Covishield from the
London, August 27 (IANS): People above 50, kindly take note. Researchers have found that older people who eat plenty of Vitamin C -- commonly found in citrus fruits, berries and vegetables -- have the best
New Delhi, August 27 (PTI): Not just the lungs, COVID-19 can affect almost all organs and the initial symptoms may be totally unrelated to chest complaints, experts at All India Institute of Medical Sciences in
August 27 (Reuters) - Moderna Inc said on Wednesday its experimental COVID-19 vaccine induced immune responses in older adults similar to those in younger participants, offering hope that it will be effective i
New Delhi, August 25 (PTI): Scientists have identified a human antibody that they say may potentially prevent or limit SARS-CoV-2 infection that causes COVID-19 disease. The researc
New Delhi, August 25 (PTI): To accelerate the process of developing and manufacturing safe and effective COVID-19 vaccines in the country that can be easily accessible and affordable for the public, a 'Miss
New Delhi, August 24 (IANS): Given their ability to abet the spread of coronavirus, doctors and health professionals are advocating stringent regulations on chewing tobacco and smokeless tobacco products l
New Delhi, August 24 (IANS): In good news for heart patients, a team of Indian researchers has found that yoga could ease symptoms in patients with atrial fibrillation -- the most common heart rhythm disorder.
August 24 (PTI): China has authorised emergency usage of COVID-19 vaccines developed by some select domestic companies, a Chinese health official has said. An emergency use authorisation,
New York, August 23 (IANS): Indian-origin researcher Sanjay Rajagopalan from the University Hospitals Harrington in the US has found that air pollution can play a role in the development of cardiometabolic dise
LONDON, August 21 (Reuters) - Russia's plan to roll-out its "Sputnik-V" COVID-19 vaccine even before full trials show how well it works is prompting concern among virus experts, who warn a partial
